Bone Metastases in Follicular Carcinoma of Thyroid
Though the association between follicular carcinoma and bone metastasis is well established, the site-wise distribution is not known. One hundred seventy-three patients of follicular carcinoma presenting between 2003 and 2011 were selected from 1093 patients of follicular lesions presenting at a single institution. Of these, 59 (34%) with bone metastasis were included in the study. Fifty of the 59 patients (84.7%) had metastasis at presentation, while 9 developed bone metastasis during follow-up. Sixty-one percent had solitary metastasis, 15 (25.4%) had multiple bone involvement, while 8 patients (13.6%) had synchronous lung metastasis. Overall, the spine was the commonest site of bone metastases, seen in 20 patients (33.9%), followed by the pelvis, skull, long bones and sternum. Bone metastasis is a known phenomenon in follicular carcinoma. The spine is the commonest site followed by the pelvis.
KeywordsAdenocarcinoma Follicular Thyroid neoplasm Bone neoplasm
Compliance with Ethical Standards
Conflict of interest
All authors declares that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study. Being a retrospective study, for this type of study formal consent is not required.
- 7.Sobrinho SM, Asa SL, Kroll TG, Nikifarav Y, DeLellis R, Farid P, Kitamura Y, Noguchi SU, Eng C, Harach HR (2004) Follicular carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU (eds) World Health Organization classification of tumors of endocrine organs. IARC Press, Lyon Eng C, pp 67–72Google Scholar
- 16.Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, Caillou B, Ricard M, Lumbroso JD, De Vathaire F, Schlumberger M (2006) Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 91(8):2892–2899CrossRefPubMedGoogle Scholar